Location: Home
  • search
  • go
  • Relate News
  • 4/22/2022U.S. SEC Adds BeyondSpring and Jrsis Healthcare to the Provisional Lis...
  • 4/22/2022Bayer Seeks Expanded Use of Prostate Cancer Drug Nubeqa in China
  • 4/22/2022Drug R&D and Product Registration News Digest April 2022 (3)
  • 4/22/2022Recent Executive Moves
  • 4/22/2022China's New Regulations on Human Genetic Resources Set to Speed Up R&D...
  • 4/21/2022CDE Solicits Comments on Two Draft Documents on Pediatric Drug Informa...
  • 4/21/2022CDE Issues the Technical Guidelines for Adverse Drug Reaction Data Sum...
  • 4/21/2022ATUM Accelerates Entry of Bioengineering Solutions into China
  • 4/21/2022Legend Makes $50M Milestone under J&J Partnership Deal for Anticancer...
  • 4/20/2022Chugai Pharma Loses China's First Drug Patent Linkage Lawsuit
  • 4/20/2022Roche Partners with Teva to Improve Lymphoma Treatments in China
  • 4/20/2022Joseph Romanelli Returns to Merck to Lead Human Health International A...
  • 4/20/2022I-Mab Reportedly Weighing Options Including Sale: Bloomberg
  • 4/20/2022PharmaDJ's China Biotech Fundraising Tracker: March 2022
  • 4/20/2022China Commercial Health Insurance Opportunities
  • 4/19/2022NMPA Withdraws Approvals of 223 Domestic and Foreign Drug Products
  • 4/19/202234 HK-Listed Chinese Biopharma Firms Saw Sharp Revenue Growth in 2021 ...
  • 4/18/2022Senior Health Official under Investigation for Corruption
  • 4/18/2022VectorBuilder to Build $500M Gene Therapy Manufacturing Facility in Ch...
  • 4/18/2022CDE Solicits Comments on the Draft Technical Guidelines for Drug Clini...
  • 4/18/2022BioBAY Suzhou - China's Biotechnology Megahub
  • 4/17/2022666 White-listed Manufacturing Enterprises Including Nearly 100 Pharma...
  • 4/16/2022Opportunities and Challenges in China for Developing Oncology Drugs fo...
  • 4/15/2022NMPA Issues the Guidelines for Pharmacovigilance Inspections
  • 4/15/2022Drug R&D and Product Registration News Digest April 2022 (2)
  • 4/14/2022Lenz and Ji Xing Announce an Exclusive Greater China License Agreement
  • 4/14/2022Bayer Receives Chinese Approval for Its Cancer Drug Vitrakvi (larotrec...
  • 4/14/2022PhIIC: Chinese Retail Biologics Sales Led by Anti-tumor Drugs in 2021
  • 4/14/2022One to Watch: China's Cell and Gene Therapies Industry (PharmExec)
  • 4/13/2022China Meheco to Distribute Ascletis's Ritonavir Tablets in Mainland Ch...
  • Page:167/799 Total number of articles:23944: [First][<<] [165] [166] [167] [168] [169] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group